Oxidation phenotype and beta-blockers.
D000319:Adrenergic beta-Antagonists / Q000378:metabolism*; D003647:Debrisoquin / Q000378:metabolism; D004983:Ethanolamines / Q000097:blood / Q000378:metabolism; D006801:Humans; D008790:Metoprolol / Q000097:blood / Q000378:metabolism; D010084:Oxidation-Reduction; D010641:Phenotype
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; C010831:bufuralol; D008790:Metoprolol; D003647:Debrisoquin